NYSE: KRC · Kilroy Realty Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.11B | $1.14B | $1.13B | $1.10B | $955.04M | $898.40M |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A | $73.11M | $72.07M | $93.43M | $93.64M | $92.75M | $99.26M |
| Total Operating Expenses | $801.65M | $801.12M | $799.78M | $772.31M | $672.37M | $659.29M |
| D&A | $349.27M | $349.83M | $348.06M | $350.67M | $303.80M | $290.35M |
| Operating Income | - | - | - | - | - | - |
| Interest Expense | $126.29M | $145.29M | $114.22M | $84.28M | $78.56M | $70.77M |
| Income Tax | - | $0 | $0 | $0 | $0 | $0 |
| Net Income | $303 | $233 | $238 | $259 | $659 | $187.10M |
| EPS - Basic | $2.33 | $1.78 | $1.80 | $1.98 | $5.38 | $1.63 |
| EPS - Diluted | $2.32 | $1.77 | $1.80 | $1.97 | $5.36 | $1.63 |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $179.32M | $165.69M | $510.16M | $347.38M | $414.08M | $731.99M |
| Accounts Receivable | $12.77M | $11.03M | $13.61M | $20.58M | $14.39M | $12.01M |
| Inventory | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - |
| Total Assets | $10.92B | $10.90B | $11.40B | $10.80B | $10.58B | $10.00B |
| Current Liabilities | - | - | - | - | - | - |
| Long-term Debt | - | - | - | - | - | - |
| Total Liabilities | $5.28B | $5.29B | $5.74B | $5.12B | $4.89B | $4.72B |
| Stockholders' Equity | $5.42B | $5.38B | $5.43B | $5.44B | $5.44B | $5.03B |
| Retained Earnings | $188.88M | $171.21M | $221.15M | $265.12M | $283.66M | ($103.13M) |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $566.31M | $541.15M | $602.59M | $592.24M | $516.40M | $455.59M |
| Investing Cash Flow | ($240.03M) | ($225.04M) | ($800.40M) | ($553.19M) | ($747.88M) | ($542.13M) |
| Financing Cash Flow | ($312.66M) | ($660.58M) | $360.60M | ($118.75M) | ($164.57M) | $833.32M |
| CapEx | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - |
| Net margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 20.8% |
| Free cash flow margin | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | 6.6% | 6.3% | 8.3% | 8.5% | 9.7% | 11.0% |
| Effective tax rate | - | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Return on assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.9% |
| Return on equity | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 3.7% |
| Return on invested capital | - | - | - | - | - | - |
| Liquidity | ||||||
| Current ratio | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - |
| Leverage | ||||||
| Debt / Equity | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - |
| Equity multiplier | 2.01 | 2.02 | 2.10 | 1.99 | 1.95 | 1.99 |
| Liabilities / Assets | 0.48 | 0.49 | 0.50 | 0.47 | 0.46 | 0.47 |
| Efficiency | ||||||
| Asset turnover | 0.10 | 0.10 | 0.10 | 0.10 | 0.09 | 0.09 |
| Inventory turnover | - | - | - | - | - | - |
| Days sales outstanding | 4d | 4d | 4d | 7d | 5d | 5d |
| Days inventory outstanding | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - |
| Growth | ||||||
| Revenue growth (YoY) | -2.0% | 0.5% | 3.0% | 14.9% | 6.3% | 7.3% |
| Revenue CAGR (3y) | 0.5% | 5.9% | 7.9% | 9.4% | - | - |
| Revenue CAGR (5y) | 4.4% | 6.3% | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - |
| Operating income growth (YoY) | - | - | - | - | - | - |
| Net income growth (YoY) | 29.9% | -2.2% | -8.2% | -60.6% | -100.0% | -4.3% |
| EPS growth (YoY) | 31.1% | -1.7% | -8.6% | -63.2% | 228.8% | -12.4% |
| EPS CAGR (3y) | 5.6% | -30.9% | 3.4% | 1.9% | - | - |
| EPS CAGR (5y) | 7.3% | -1.0% | - | - | - | -7.6% |
| FCF growth (YoY) | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - |
| Book value growth (YoY) | 0.7% | -0.8% | -0.2% | -0.1% | 8.2% | 17.2% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$19.08M totalOffice And Life Science Properties Segment$19.08M · 100.0%
Stability scores
Piotroski F-score
FY 2025 · 9-point quality
5/9
Neutral
- ✓Net income positive
- ✓Operating cash flow positive
- ✓ROA improved YoY
- ✓Cash flow > net income
- -Long-term debt decreased
- -Current ratio improved
- ✓No share dilution
- -Gross margin improved
- ✗Asset turnover improved
Peer comparison
Same SIC group: Real Estate Investment Trusts
Comparing KILROY REALTY CORP against the 5 most active filers in the same SIC group.